Testosterone + Hybrid Exercise for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a combination of exercise and testosterone to improve health and wellbeing in individuals with spinal cord injuries. It focuses on those with a cervical or thoracic spinal cord injury for at least six months who primarily use a wheelchair. Researchers aim to determine if this combination can enhance aerobic capacity, function, metabolism, bone health, and overall wellbeing more effectively than exercise with a placebo. Participants should not have musculoskeletal conditions or recent serious health events, such as a heart attack. As a Phase 2 trial, the research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to important early-stage findings.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you must stop taking your current medications. However, you cannot participate if you are using testosterone or other anabolic therapies, or if you are on certain blood thinners like Coumadin, heparin, or rivaroxaban. Please consult with the trial coordinators for more details.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have used testosterone or similar therapies in the last 6 months, or if you are on certain blood thinners like Coumadin or heparin.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that combining leg exercises using electrical stimulation with arm workouts is generally safe for people with spinal cord injuries. Most participants handle it well, with high attendance and few dropouts.
When used correctly, testosterone undecanoate is also considered safe. It helps improve muscle and bone health in men with spinal cord injuries and usually doesn't cause major side effects. However, some concern exists about possible heart risks, so regular monitoring is important.
Previous studies have found both treatments to be well-tolerated, making them promising options for those considering joining this trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the hybrid exercise approach for spinal cord injury because it combines functional electrical stimulation (FES) with leg cycling and arm ergometry, which is not typical in standard care options. Unlike traditional therapies that may focus on passive or isolated muscle training, this multi-modality intervention aims to actively engage both the upper and lower body, potentially leading to more comprehensive rehabilitation outcomes. Additionally, the use of testosterone undecanoate in one of the treatment arms could enhance muscle strength and recovery, offering a novel combination not currently seen in typical rehabilitation programs. This dual approach could open new doors for improved physical function and quality of life for individuals with spinal cord injuries.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that hybrid exercise, which combines leg cycling with electrical stimulation and arm exercise, can greatly improve fitness in people with spinal cord injuries (SCI). One study found this exercise more effective than others, with a moderate positive impact on heart and lung health. Electrical stimulation activates more muscles, which is crucial for boosting fitness levels despite the injury.
In this trial, participants in the multi-modality intervention group will receive both hybrid exercise and Testosterone undecanoate. Testosterone undecanoate has been shown to increase muscle mass, improve bone health, and boost metabolism in people with SCI. Studies have found that testosterone therapy can enhance muscle strength and energy, improve insulin use, and reduce belly fat. Together, these treatments show promise for improving overall health and function in individuals with SCI.13467Who Is on the Research Team?
Shalender Bhasin, MD
Principal Investigator
Brigham and Women's Hospital
Are You a Good Fit for This Trial?
This trial is for men and women aged 19-70 with spinal cord injury (SCI), at least 6 months post-injury, who primarily use a wheelchair. Participants must be medically stable, able to follow directions, and if female and of reproductive potential, agree to use effective contraception during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Studies and Day 1
Baseline assessments and initial setup for the intervention
Treatment
Participants receive the multimodality intervention or placebo for 16 weeks
End of Study Assessments
Final assessments to evaluate the outcomes of the intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hybrid Exercise
- Testosterone Undecanoate
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Spaulding Rehabilitation Hospital
Collaborator